CalciMedica (CALC) Convertible Debt (2022)
CalciMedica's (CALC) quarterly Convertible Debt came in at $5.2 million in Q4 2022.
CalciMedica (CALC) Convertible Debt (2022) Analysis & Trends
CalciMedica (CALC) has 1 years of Convertible Debt data on file, last reported at $5.2 million in Q4 2022.
- Quarterly Convertible Debt changed N/A year-over-year to $5.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $5.2 million (changed N/A YoY) and the FY2022 annual result came in at $5.2 million, changed N/A from the prior year.
- Convertible Debt steadied at $5.2 million in Q4 2022.
- In the past five years, Convertible Debt ranged from a high of $5.2 million in Q4 2022 to a low of $5.2 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - |
| 10 | CalciMedica | 9.82 Mn | -8.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 5.16 Mn |